Core Insights - Analysts project that Bally's (BALY) will report a quarterly loss of -$0.71 per share, reflecting a year-over-year increase of 64.3% [1] - Revenue is expected to reach $659.65 million, marking a 4.7% increase from the same quarter last year [1] - The consensus EPS estimate has remained unchanged over the past 30 days, indicating a reassessment by covering analysts [1] Revenue Estimates - Analysts estimate 'Revenue- Casinos & Resorts' at $392.60 million, representing an 11.1% increase from the prior-year quarter [4] - 'Revenue- International Interactive' is projected to be $211.30 million, indicating a decline of 8.5% from the year-ago quarter [4] - 'Revenue- North America Interactive' is expected to reach $54.80 million, reflecting a 20% increase from the prior-year quarter [4] EBITDAR Estimates - 'Adjusted EBITDAR- International Interactive' is expected to be $82.90 million, down from $90.03 million reported in the same quarter last year [5] - Analysts project 'Adjusted EBITDAR- Casinos & Resorts' at $109.15 million, compared to $100.44 million from the previous year [5] Stock Performance - Over the past month, shares of Bally's have increased by 28%, while the Zacks S&P 500 composite has only risen by 1.3% [5] - Currently, Bally's holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [5]

Core Insights - American Healthcare REIT (AHR) is expected to report quarterly earnings of $0.42 per share, reflecting a year-over-year increase of 16.7% [1] - Projected revenues for AHR are anticipated to be $565.26 million, which represents a 7.9% increase from the same quarter last year [1] - The consensus EPS estimate has remained stable over the last 30 days, indicating a collective reevaluation by analysts [1] Revenue Estimates - Analysts predict 'Revenues- Resident fees and services' to be $535.68 million, showing a year-over-year increase of 12.3% [4] - The consensus estimate for 'Revenues- Real estate revenue' is $39.47 million, indicating a decline of 16% from the prior-year quarter [4] Other Financial Metrics - 'Depreciation and amortization' is forecasted to reach $42.39 million [5] - AHR shares have increased by 12% over the past month, outperforming the Zacks S&P 500 composite, which saw a 1% increase [5] - AHR holds a Zacks Rank 2 (Buy), suggesting it is expected to outperform the overall market in the near future [5]

Core Insights - Analysts project that Enterprise Products Partners (EPD) will report quarterly earnings of $0.67 per share, reflecting a year-over-year increase of 3.1% [1] - Revenue is expected to reach $12.59 billion, which represents an 8.6% decline from the same quarter last year [1] - The consensus EPS estimate has been revised downward by 1.7% in the past 30 days, indicating a reassessment by covering analysts [2] Financial Metrics - Analysts estimate 'NGL Pipelines & Services net - NGL fractionation volumes per day' at 1,719.13 thousand barrels, up from 1,611.00 thousand barrels a year ago [5] - The forecast for 'NGL Pipelines & Services net - Fee-based natural gas processing per day' is 7,711.24 thousand barrels, compared to 6,804.00 thousand barrels last year [5] - The consensus for 'NGL Pipelines & Services net - NGL pipeline transportation volumes per day' is 4,562.86 thousand barrels, an increase from 4,223.00 thousand barrels in the same quarter last year [6] - 'Natural Gas Pipelines & Services net - Natural gas transportation volumes per day' are estimated at 20,723 billion British thermal units, up from 19,090 billion British thermal units a year ago [7] - 'Petrochemical Services net - Butane isomerization volumes per day' are expected to be 120.61 thousand barrels, compared to 116.00 thousand barrels last year [7] - 'Petrochemical Services net - Propylene fractionation volumes per day' is projected at 113.58 thousand barrels, slightly up from 113.00 thousand barrels a year ago [8] - 'Petrochemical Services net - Octane enhancement and related plant sales volumes per day' is expected to reach 38.03 thousand barrels, compared to 37.00 thousand barrels last year [9] Operating Margins - 'NGL Pipelines & Services' gross operating margin is forecasted to be $1.37 billion, compared to $1.34 billion last year [10] - 'Crude Oil Pipelines & Services' gross operating margin is projected at $377.00 million, down from $401.00 million in the same quarter last year [11] - 'Natural Gas Pipelines & Services' gross operating margin is expected to reach $402.33 million, up from $349.00 million a year ago [11] - 'Petrochemical & Refined Products Services' gross operating margin is estimated at $343.04 million, compared to $363.00 million last year [12] Stock Performance - Over the past month, shares of Enterprise Products have returned -0.3%, while the Zacks S&P 500 composite has changed by +3.6% [12] - Currently, EPD holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the overall market in the near future [12]

Core Viewpoint - Analysts project Novartis (NVS) will report quarterly earnings of $2.26 per share, reflecting a 9.7% year-over-year increase, with revenues expected to reach $13.9 billion, an 8.4% increase from the same quarter last year [1]. Earnings Estimates - The consensus EPS estimate has remained unchanged over the last 30 days, indicating a collective reevaluation by analysts [1][2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock performance [2]. Revenue Projections - Analysts expect 'Revenues- Oncology- Tafinlar + Mekinist- Total' to be $555.75 million, a 4.1% increase year-over-year [4]. - 'Revenues- Net sales to third parties' are projected to reach $14.07 billion, indicating a 9.8% year-over-year change [4]. - 'Revenues- Oncology- Kisqali- Total' is estimated at $1.29 billion, reflecting a significant 64.2% year-over-year increase [4]. Specific Revenue Metrics - 'Revenues- Immunology- Cosentyx- Total' is expected to reach $1.72 billion, a 1.9% increase from the prior year [5]. - 'Revenues- Oncology- Tasigna- US' is projected at $119.43 million, showing a decline of 47.2% year-over-year [5]. - 'Revenues- Oncology- Promacta/Revolade- US' is estimated at $180.08 million, indicating a 41.2% decrease from the year-ago quarter [5]. Additional Revenue Insights - 'Revenues- Immunology- Cosentyx- US' is expected to be $990.42 million, a slight decrease of 0.3% year-over-year [6]. - 'Revenues- Cardiovascular- Entresto- US' is projected at $927.94 million, reflecting a 1.8% increase from the previous year [6]. - 'Revenues- Oncology- Tasigna- ROW' is estimated at $149.03 million, indicating a 22.8% decline year-over-year [7]. - 'Revenues- Oncology- Tafinlar + Mekinist- ROW' is expected to reach $320.55 million, a 4.4% increase year-over-year [7]. - 'Revenues- Oncology- Promacta/Revolade- ROW' is projected at $267.72 million, reflecting a 1.8% increase [7]. - 'Revenues- Immunology- Cosentyx- ROW' is expected to be $734.58 million, indicating a 4.9% increase from the prior year [8]. Stock Performance - Novartis shares have increased by 6.9% over the past month, outperforming the Zacks S&P 500 composite, which saw a 0.2% increase [8].

Core Viewpoint - Nutrien (NTR) is expected to report quarterly earnings of $2.40 per share, a 2.6% increase year-over-year, with revenues projected at $10.61 billion, reflecting a 4.5% year-over-year growth [1]. Earnings Estimates - Over the last 30 days, the consensus EPS estimate has been revised upward by 14.2%, indicating analysts' reassessment of their initial forecasts [2]. - Changes in earnings estimates are crucial for predicting investor reactions to the stock, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock price performance [3]. Revenue Projections - Analysts project 'Sales- Retail (Nutrient Ag Solutions)- Total' to reach $8.40 billion, a year-over-year increase of 4.1% [5]. - The consensus estimate for 'Sales- Nitrogen' is $1.25 billion, indicating a 4.9% increase from the previous year [5]. - 'Sales- Potash' is estimated at $892.38 million, reflecting a 6.7% year-over-year change [5]. - 'Sales- Phosphate' is expected to be $436.29 million, showing a decline of 3.3% from the prior year [6]. Sales Volumes - 'Potash - Sales volumes - Total' is projected at 3,613 thousand tons, up from 3,563 thousand tons year-over-year [6]. - 'Nitrogen - Sales volumes - Total' is expected to reach 2,947 thousand tons, compared to 2,818 thousand tons in the same quarter last year [7]. - 'Phosphate - Sales volumes - Total' is forecasted at 575 thousand tons, down from 584 thousand tons year-over-year [8]. - 'Potash - Sales volumes - North America' is estimated at 1,004 thousand tons, compared to 914 thousand tons in the same quarter last year [9]. - 'Nitrogen - Sales volumes - Ammonia' is projected to be 738 thousand tons, up from 698 thousand tons year-over-year [10]. Price Projections - The average selling price per tonne for 'Phosphate - Industrial and feed' is expected to be $755, down from $830 year-over-year [7]. - The average selling price per tonne for 'Phosphate - Total' is projected at $651, compared to $667 in the previous year [8]. Stock Performance - Nutrien shares have decreased by 1.4% over the past month, contrasting with the Zacks S&P 500 composite's increase of 2.3% [11].

Core Viewpoint - The upcoming earnings report from Automatic Data Processing (ADP) is anticipated to show a quarterly earnings per share (EPS) of $2.22, reflecting a 6.2% increase year-over-year, with revenues expected to reach $5.05 billion, indicating a 5.9% growth compared to the previous year [1]. Earnings Projections - The consensus EPS estimate has been revised down by 0.1% over the last 30 days, indicating a collective reevaluation by analysts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Revenue Estimates - Analysts project 'Revenues- Interest on funds held for clients' to be $286.31 million, a 3.4% increase from the year-ago quarter [5]. - The consensus estimate for 'Revenues- PEO revenues' is $1.63 billion, suggesting a 5.2% year-over-year change [5]. - 'Revenues- Revenues, other than interest on funds held for clients and PEO revenues' is expected to reach $3.13 billion, indicating a 6.3% increase year-over-year [6]. - The average prediction for 'Segment revenues- Employer Services' is $3.43 billion, reflecting a 6.4% change from the previous year [6]. - 'Segment revenues- PEO Services' is projected to be $1.63 billion, a 5% increase from the year-ago quarter [7]. Employee Metrics - Analysts estimate that the 'Average paid PEO worksite employees during the period' will reach 757, compared to 742 in the previous year [7]. Market Performance - ADP shares have shown a return of +1.1% over the past month, while the Zacks S&P 500 composite has increased by +4.6% [7].

Core Insights - CoStar Group (CSGP) is expected to report quarterly earnings of $0.14 per share, a decline of 6.7% year-over-year, with revenues forecasted at $771.67 million, reflecting a 13.8% increase compared to the same period last year [1] Earnings Estimates - The consensus EPS estimate for the quarter has not changed over the past 30 days, indicating that analysts have maintained their initial projections [2] - Changes in earnings estimates are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate revisions and short-term stock price performance [3] Revenue Projections - The consensus estimate for CoStar's total revenues is $267.89 million, indicating a year-over-year change of +5.9% [5] - Analysts project 'Revenues- Information Services' to reach $36.74 million, reflecting a +10% change from the prior-year quarter [5] - 'Revenues- Other Marketplaces' are expected to be $50.20 million, showing a significant increase of +60.9% year-over-year [5] - 'Revenues- LoopNet' is forecasted at $74.65 million, indicating a +6.9% change [6] - 'Revenues- Residential' is expected to be $31.02 million, reflecting an +18.4% increase [6] - The average prediction for 'Revenues- Multifamily' stands at $293.26 million, indicating an +11% change from the prior-year quarter [6] Stock Performance - CoStar shares have increased by +7% in the past month, outperforming the Zacks S&P 500 composite, which has risen by +4.2% [6] - CoStar holds a Zacks Rank 3 (Hold), suggesting it is expected to closely follow overall market performance in the near term [6]

Core Insights - Ooma (OOMA) is expected to report quarterly earnings of $0.18 per share, reflecting a 28.6% increase year-over-year [1] - Analysts forecast revenues of $64.82 million, indicating a 3.7% year-over-year growth [1] - The consensus EPS estimate has remained unchanged over the last 30 days, suggesting stability in analyst projections [1] Revenue Projections - Analysts estimate 'Revenue- Product and other' to reach $4.56 million, representing an 11.1% increase from the previous year [4] - 'Revenue- Subscription and services' is projected to be $60.92 million, showing a year-over-year change of 4.3% [4] Gross Margin Insights - The consensus for 'Gross Margin- Subscription and services' is expected to be 70.7%, an improvement from the year-ago figure of 70% [4] Stock Performance - Ooma shares have increased by 8.7% in the past month, outperforming the Zacks S&P 500 composite's 8.2% increase [5] - Ooma holds a Zacks Rank 3 (Hold), indicating it is expected to closely follow overall market performance in the near term [5]

Core Insights - American Public Education (APEI) is expected to report quarterly earnings of $0.15 per share, a significant increase of 350% year-over-year [1] - Forecasted revenues for APEI are $161.94 million, reflecting a year-over-year increase of 4.9% [1] - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analysts' projections [1] Revenue Projections - Revenues for Rasmussen University (RU) are projected to be $57.19 million, representing a year-over-year increase of 7.6% [4] - Revenues for Hondros College, Nursing Programs (HCN) are estimated at $18.07 million, indicating a year-over-year increase of 9.9% [4] - Revenues for American Military & Public University (APUS) are forecasted to reach $82.42 million, reflecting a year-over-year change of 2.2% [5] Market Performance - APEI shares have increased by 5.6% over the past month, compared to a 11.3% increase in the Zacks S&P 500 composite [6] - APEI holds a Zacks Rank of 3 (Hold), suggesting it is expected to perform in line with the overall market in the near future [6]

Core Viewpoint - Tradeweb Markets (TW) is expected to report quarterly earnings of $0.85 per share, reflecting a 19.7% increase year-over-year, with revenues projected at $507.07 million, a 24.1% increase compared to the previous year [1]. Earnings Projections - Over the last 30 days, the consensus EPS estimate for the quarter has been revised upward by 2.5%, indicating analysts' reassessment of their initial forecasts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Revenue Estimates - Analysts project 'Revenue by Asset Class- Total Variable' to be $378.73 million, marking a 26.6% increase from the year-ago quarter [5]. - The estimate for 'Revenue by Asset Class- Other' is $6.33 million, indicating a year-over-year change of 6.6% [5]. - 'Revenue by Asset Class- Rates- Variable' is expected to reach $194.92 million, reflecting a 26.8% increase from the previous year [5]. - 'Revenue by Asset Class- Rates- Fixed' is estimated at $65.86 million, showing a 9.1% increase year-over-year [6]. Volume Metrics - The average daily volumes for 'Rates - Cash' are projected at $554.53 billion, up from $461.83 billion a year ago [6]. - Total average daily volumes are expected to reach $2,501.84 billion, compared to $1,899.64 billion in the same quarter last year [7]. - 'Average Daily Volumes - Money Markets' is estimated at $997.13 billion, significantly higher than the $576.57 billion reported in the same quarter last year [7]. - 'Average Daily Volumes - Equities' is projected at $28.62 billion, compared to $27.45 billion in the previous year [8]. - 'Average Daily Volumes - Credit' is expected to reach $42.25 billion, up from $34.92 billion a year ago [8]. - 'Average Daily Volumes - Rates' is estimated at $1,434.26 billion, compared to $1,260.7 billion in the same quarter last year [9]. Fee Estimates - Analysts predict 'Average variable fees per million dollars of volume - Equities' to be $16.72, up from $14.68 a year ago [9]. - 'Average variable fees per million dollars of volume - Credit' is expected to reach $45.46, down from $50.39 in the previous year [10]. Stock Performance - Over the past month, Tradeweb shares have recorded a return of -8.1%, compared to a -0.8% change in the Zacks S&P 500 composite [10].